ArticleFrontiers in cardiovascular medicine2026
Prognostic value of CALLY index in combination with the GRACE score among patients with acute myocardial infarction: a retrospective cohort study.
Article in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: The study aimed to investigate the prognostic value of the CRP-albumin-lymphocyte (CALLY) index for adverse outcomes in patients with AMI and evaluate the potential value of combining the CALLY index with the GRACE score to improve prognosis. Methods: This study enrolled 1,127 patients with acute myocardial infarction (AMI) admitted to the Sinopharm Dongfeng General Hospital from 2021 to 2023. Patients were stratified into two cohorts based on the median CALLY index score. Kaplan-Meier survival analysis, multivariable Cox proportional hazards models, and restricted cubic spline (RCS) analysis were used to assess the association between CALLY index levels and major adverse cardiovascular and cerebrovascular events (MACCE). Time-dependent receiver operating characteristic (Time-ROC) curves were constructed to evaluate the prognostic value of the CALLY index for AMI patients. Additionally, subgroup analyses were conducted to assess the robustness and consistency of this association across different clinical characteristics. Results: During a median follow - up of 24 months, a total of 243 patients (24%) experienced a major adverse cardiovascular event (MACCE). The CALLY index in the MACCE group was significantly lower than that in the non - MACCE group. In the fully adjusted model, whether treated as a continuous variable (HR = 0.68; 95% CI: 0.51-0.90) or as a categorical variable (HR = 0.29; 95% CI: 0.19-0.44; Conclusion: The CALLY index was closely associated with patient prognosis in acute myocardial infarction (AMI) and significantly enhanced the predictive accuracy of the traditional GRACE score. The CALLY index was poised to emerge as a novel biomarker for prognostic stratification in AMI.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.